(Q52602775)

4 May 2018

14 references

20 June 2019

25 June 2019

4 August 2019

6 August 2019

1 October 2019

7 November 2019

8 November 2019

16 November 2019

18 November 2019

1 June 2020

2 October 2020

23 November 2020

7 December 2020

20 December 2020

Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases. (English)

1 reference

4 May 2018

pharmaceutical preparation

1 reference

4 August 2019

1 reference

6 August 2019

1 reference

1 October 2019

1 reference

7 November 2019

1 reference

7 November 2019

1 reference

8 November 2019

macromolecular substance

1 reference

16 November 2019

1 reference

18 November 2019

1 reference

2 October 2020

1 reference

23 November 2020

respiratory tract infection

2 references

7 December 2020

20 December 2020

1 reference

20 December 2020

Rika Nakahashi-Ouchida

series ordinal

1

1 reference

4 May 2018

Yoshikazu Yuki

series ordinal

2

1 reference

4 May 2018

Hiroshi Kiyono

series ordinal

3

1 reference

4 May 2018

publication date

6 April 2018

1 reference

4 May 2018

Human Vaccines & Immunotherapeutics

19 July 2018

14 references

20 June 2019

25 June 2019

4 August 2019

6 August 2019

1 October 2019

7 November 2019

8 November 2019

16 November 2019

18 November 2019

1 June 2020

2 October 2020

23 November 2020

7 December 2020

20 December 2020

15 references

4 May 2018

20 June 2019

25 June 2019

4 August 2019

6 August 2019

1 October 2019

7 November 2019

8 November 2019

16 November 2019

18 November 2019

1 June 2020

2 October 2020

23 November 2020

7 December 2020

20 December 2020

1-27

1 reference

4 May 2018

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

copyright license

14 references

20 June 2019

25 June 2019

4 August 2019

6 August 2019

1 October 2019

7 November 2019

8 November 2019

16 November 2019

18 November 2019

1 June 2020

2 October 2020

23 November 2020

7 December 2020

Intranasal immunization with dry powder vaccines

20 December 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodents

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Modes of Action for Mucosal Vaccine Adjuvants

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Nanogel-based nasal ghrelin vaccine prevents obesity.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Pneumococcal vaccination.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Nanogel-based antigen-delivery system for nasal vaccines.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Dynamics of the pneumococcal population causing acute exacerbations in COPD patients in a Barcelona hospital (2009-12): comparison with 2001-04 and 2005-08 periods

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Serotype replacement in disease after pneumococcal vaccination

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Current status of pneumococcal vaccines: lessons to be learned and new insights

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Self-assembled cationic nanogels for intracellular protein delivery

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Mucosal immunity and vaccines

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Pneumonia in the very old

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Mucosal immunity: some historical perspective on host-pathogen interactions and implications for mucosal vaccines.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Ghrelin enhances appetite and increases food intake in humans

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Endothelial surface charge of intestinal mucosal capillaries and its modulation by dextran

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6183202

Nasal lymphoid tissue (NALT) as a mucosal immune inductive site

2 November 2018

1 reference

12 December 2020

Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production

1 reference

12 December 2020

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

12 December 2020

A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice

1 reference

12 December 2020

10.1080/21645515.2018.1461298

Identifiers

DOI

1 reference

4 May 2018

release_fl6jc2y2gjhppkmntu4hirwjpe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fl6jc2y2gjhppkmntu4hirwjpe

24 November 2022

mapped directly with Wikidata item

PMC publication ID

6183202

0 references

1 reference

4 May 2018